晶泰控股(02228)获港交所正式批准完成28.66亿港元零息CB,国际长线资本扎堆认购
XTALPIXTALPI(HK:02228) 智通财经网·2026-01-29 00:46

Core Viewpoint - Crystal Tech Holdings plans to issue zero-coupon convertible bonds totaling HKD 28.66 billion, with proceeds aimed at enhancing R&D capabilities, commercial capacity, building facilities, and supplementing working capital [1] Group 1: Bond Issuance Details - The bonds will mature in 2027 and are structured to balance financing efficiency, risk control, and the rights of both the issuer and investors [1] - The initial conversion price is set at HKD 13.85 per share, representing a premium of approximately 20% over the company's stock price of HKD 11.54 on January 7, and a premium of 31.7% over the average closing price of HKD 10.516 over the previous five trading days [1] - If fully converted, approximately 207 million new shares will be issued, accounting for 4.81% of the current issued share capital and 4.59% of the enlarged share capital, indicating a relatively moderate dilution [1] Group 2: Investor Participation and Market Response - The zero-coupon structure significantly reduces short-term financing costs for Crystal Tech Holdings, aligning with the company's current business development stage [2] - The high conversion premium reflects the company's confidence in its value and provides effective protection for existing shareholders, filtering out speculative investors [2] - The bond issuance received over 10 times subscription coverage, with participation from leading international institutions such as BlackRock, Allianz, D.E. Shaw, Amundi, and Citadel, indicating strong recognition of the company's business prospects [2] Group 3: Industry Context and Strategic Implications - Crystal Tech Holdings operates at the intersection of quantum physics, artificial intelligence, and large-scale standardized experimental robotics, covering multiple sectors including pharmaceuticals, energy, agriculture, new materials, and consumer goods [2] - The involvement of top-tier investors like BlackRock and Allianz underscores confidence in the AI and biopharmaceutical sectors, as well as recognition of the company's technological platform and commercialization potential [3] - The issuance of zero-coupon convertible bonds is expected to inject sufficient funds for R&D upgrades and commercial expansion, while also optimizing the shareholder structure and enhancing the company's influence in global capital markets [4]

晶泰控股(02228)获港交所正式批准完成28.66亿港元零息CB,国际长线资本扎堆认购 - Reportify